A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations
Author:
Affiliation:
1. Biostatistics Group, Center for Product Evaluation Pharmaceuticals and Medical Devices Agency Tokyo Japan
2. Division of Biostatistics and Data Science, Clinical Research Center Tokyo Medical and Dental University Tokyo Japan
Funder
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2049
Reference32 articles.
1. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
2. Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung Cancer
3. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
4. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
5. Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunity;Frontiers in Oncology;2023-11-14
2. Practical basket design for binary outcomes with control of family-wise error rate;BMC Medical Research Methodology;2023-02-27
3. Introduction to Basket Trials;Bayesian Adaptive Design for Immunotherapy and Targeted Therapy;2023
4. Bayesian Modelling Strategies for Borrowing of Information in Randomised Basket Trials;Journal of the Royal Statistical Society Series C: Applied Statistics;2022-10-28
5. Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology;Frontiers in Oncology;2022-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3